
ISSCR 2026 Annual Meeting
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to ISSCR 2026 Annual Meeting — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
International Society for Stem Cell Research 2026
Important note before we finalize buyer targeting: please share your client website or product page so I can review it and identify the best buyers based on the exact solution you are selling. The ideal attendee and company targets change a lot depending on whether the client sells lab equipment, reagents, imaging, software, clinical research services, recruitment solutions, diagnostics, storage, logistics, or conference sponsorships.
Below is a detailed buyer-analysis style event profile for International Society for Stem Cell Research 2026, written for attendee-list, buyer-list, and lead-targeting use.
Event Overview
Event type: Stem cell research conference, regenerative medicine, cell therapy, translational science, biotechnology, life sciences, academic research, and clinical innovation.
Typical audience: Scientists, principal investigators, research directors, biotech leaders, translational medicine professionals, clinical researchers, laboratory managers, investors, equipment vendors, and academic-industry collaborators.
Expected value: Very high for B2B targeting because the audience is composed of specialized decision-makers, research influencers, and technology buyers across biotech, pharma, academia, diagnostics, and clinical development.
1️⃣ Who attends: Buyers / Attendees
This event is a premium scientific and commercial networking environment focused on stem cell biology, regenerative medicine, and translational research. Unlike a general medical meeting, the attendee base here is heavily concentrated with technical and professional roles that directly influence purchasing, partnerships, funding, research direction, and vendor selection.
Main attendee groups include:
- Principal investigators and lab heads
- Stem cell researchers and postdoctoral fellows
- Translational medicine and regenerative medicine scientists
- Clinical researchers and physician-scientists
- Biotech and pharma R&D leaders
- Laboratory directors and facility managers
- Core facility managers for cell culture, genomics, imaging, and flow cytometry
- Technology transfer and innovation officers
- Academic department heads, deans, and research administrators
- Venture capital and biotech investment professionals
- Suppliers of lab instruments, reagents, consumables, software, and storage systems
- Contract research organizations and clinical trial service providers
- Regulatory affairs and quality assurance professionals
In buyer-list terms, the strongest records are usually not students or general attendees, but rather professionals in research leadership, lab operations, product evaluation, business development, and translational partnerships.
2️⃣ Where the show is happening + attendee geographic origin
Show location: The 2026 meeting location should be confirmed from the official event page, as venue and city can vary by year. For this reason, the most reliable approach is to treat this as a globally distributed scientific audience event rather than a city-only event.
Attendee origin: The audience is typically international, with strong participation from the United States, Canada, Europe, the United Kingdom, Japan, South Korea, Singapore, China, Australia, and other major life-science and biotechnology markets. Because stem cell research is globally collaborative, many attendees travel internationally to present papers, attend sessions, and meet vendors or collaborators.
Best geographic targeting:
- North America for strong biotech and academic research density
- Europe for translational medicine and cell therapy leaders
- Asia-Pacific for advanced regenerative medicine and biotech manufacturing
- Global academic centers, teaching hospitals, and research institutes
3️⃣ Audience reach: Local / National / Global
Reach type: Global
This is a globally recognized scientific conference with highly specialized international participation. While local attendance depends on the final venue, the real audience reach is not local or national only. The event has a strong international footprint because it attracts researchers, labs, institutions, and commercial partners from multiple regions and scientific ecosystems.
For lead generation, this means the event is excellent for:
- Global biotech and life sciences campaigns
- Research tool and laboratory equipment companies
- Cell therapy and regenerative medicine suppliers
- Clinical research and translational science service providers
- Academic and hospital research partnerships
4️⃣ Sample buyer company names + websites
Below are sample buyer-style companies that are strong fits for this event. These are not just random organizations; they represent likely buyers, influencers, collaborators, sponsors, exhibitors, or strategic partners in stem cell research, cell therapy, regenerative medicine, lab workflows, and biomanufacturing.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | thermofisher.com | Director, Cell Biology Marketing / Product Manager, Stem Cell Tools / Clinical Research Solutions Leader | Major supplier across cell culture, sequencing, imaging, consumables, and bioprocess workflows; highly relevant to stem cell research buyers. |
| 2 | Merck KGaA / MilliporeSigma | sigmaaldrich.com | Business Development Manager, Life Sciences / Product Marketing Manager, Cell Culture | Strong fit for reagents, media, antibodies, and lab workflows used heavily in academic and translational stem cell research. |
| 3 | BD Biosciences | bd.com | Flow Cytometry Product Manager / Strategic Accounts Manager / Cell Analysis Marketing Lead | Excellent fit for cell sorting, flow cytometry, immune profiling, and cell analysis applications in regenerative medicine. |
| 4 | Danaher | danaher.com | Vice President, Life Sciences Strategy / Segment Marketing Director | Portfolio spans diagnostics, lab automation, life sciences tools, and research platforms used by high-end research institutions. |
| 5 | Illumina | illumina.com | Genomics Product Manager / Scientific Marketing Manager / Strategic Partnerships Lead | Genome analysis and single-cell research are important in stem cell science and translational studies. |
| 6 | Fujifilm Cellular Dynamics | fujifilmcdi.com | Business Development Director / Product Manager, iPSC Solutions | Directly aligned with induced pluripotent stem cell platforms, cell therapy development, and research-grade cell products. |
| 7 | Lonza | lonza.com | Cell & Gene Therapy Product Manager / Marketing Director, Biologics | Very strong fit for cell therapy, manufacturing, media, and advanced biologics workflows. |
| 8 | Miltenyi Biotec | miltenyibiotec.com | Product Manager, Cell Separation / Regenerative Medicine Business Development Lead | Widely used in cell enrichment, cell sorting, and sample processing for stem cell and translational research. |
| 9 | Stemcell Technologies | stemcell.com | Regional Sales Manager / Scientific Affairs Manager / Product Marketing Manager | Highly relevant because the company is focused on stem cell science, cell culture, and research-support products. |
| 10 | Sartorius | sartorius.com | Bioprocess Sales Director / Lab Automation Product Manager | Strong for lab automation, filtration, bioprocessing, and scale-up needs in translational and manufacturing settings. |
| 11 | Takara Bio | takara-bio.com | Product Manager, Cell Engineering / Strategic Sales Manager | Relevant to gene expression, cell engineering, transfection, and advanced cell research. |
| 12 | Bio-Techne | bio-techne.com | Director, Research Reagents / Market Development Manager | Very strong fit for proteins, antibodies, assays, and tools that support stem cell and translational work. |
| 13 | Charles River Laboratories | criver.com | Business Development Director, Preclinical Services / Translational Science Leader | Excellent for preclinical research, model systems, and translational development partnerships. |
| 14 | WuXi AppTec | wuxiapptec.com | Director, Cell Therapy Services / Business Development Executive | Strong match for outsourcing, discovery, process development, and advanced therapy services. |
| 15 | AGC Biologics | agcbio.com | Commercial Development Director / Head of Cell Therapy CDMO | Relevant for cell therapy manufacturing and scale-up partnerships. |
| 16 | Sana Biotechnology | sana.com | Research Program Manager / Business Development Director | Cell engineering and regenerative medicine focus makes this a strategic buyer profile. |
| 17 | BlueRock Therapeutics | bluerocktx.com | Director, Translational Research / External Innovation Manager | Highly aligned with cell therapy and regenerative medicine collaborations. |
| 18 | Astellas Pharma | astellas.com | Director, Research Partnerships / Cell Therapy Strategy Lead | Large pharma with regenerative medicine interest; good for research partnerships and clinical development outreach. |
Top 5 best samples to send client first: Thermo Fisher Scientific, MilliporeSigma, BD Biosciences, Fujifilm Cellular Dynamics, and Lonza. These give you a strong cross-section of consumables, tools, cell products, and advanced therapy workflows.
5️⃣ Job profiles, industries & event type
Best job profiles to target:
- Principal Investigator
- Scientific Director
- Research Director
- Lab Director
- Stem Cell Scientist
- Translational Research Director
- Regenerative Medicine Lead
- Cell Therapy Program Manager
- Bioprocess Development Manager
- Product Manager, Life Sciences
- Business Development Director, Biotechnology
- Clinical Research Director
- Technology Transfer Manager
- Core Facility Manager
- Scientific Affairs Manager
- Market Development Manager
- R&D Manager
- Procurement Manager, Lab Supplies
Best industry categories to use from your industry list:
- Biotechnology
- Pharmaceuticals
- Research
- Hospital & Health Care
- Medical Devices
- Higher Education
- Education Management
- Information Services
- Health, Wellness & Fitness
- Management Consulting
- Medical Practice
- Biotechnology-related academic and research institutions
- Professional Training & Coaching, when targeting scientific education services
- Laboratory services and scientific instrumentation companies through company keywords
Event type positioning: This is a high-level scientific congress with strong commercial value for research suppliers, translational medicine companies, CDMOs, cell therapy organizations, diagnostics, and academic research ecosystems.
6️⃣ Estimated attendance: expected total footfall
Because final 2026 registration data may not yet be fully public, the safest way to estimate footfall is by historical scale and the nature of the organization. This event typically draws a specialized but substantial global audience.
Estimated attendance range: approximately 2,000 to 4,000+ attendees, depending on venue, city, and final program depth.
Likely composition: scientific presenters, researchers, clinicians, exhibitors, sponsors, company delegates, and academic leaders.
Even when total footfall is smaller than a large trade show, the value per attendee is usually much higher because the audience is dense with decision-makers, research influencers, and technical budget holders.
7️⃣ Key focus areas & buyer engagement
Main focus areas of the event:
- Stem cell biology and developmental biology
- Regenerative medicine and tissue repair
- Cell therapy development
- Gene editing and cell engineering
- Translational science and clinical application
- Single-cell analysis and multi-omics
- Biomaterials, scaffolds, and tissue engineering
- Bioprocessing and GMP manufacturing
- Ethics, regulation, and policy
- New technologies for imaging, assay development, and cell characterization
Buyer engagement angle:
The strongest engagement strategy is to target organizations that need access to scientific decision-makers, lab buyers, translational leaders, and commercialization teams. Rather than selling a generic attendee list, the value proposition should be framed around reaching specific segments such as:
- Lab and research equipment buyers
- Scientific procurement influencers
- Translational and clinical innovation leaders
- Biotech and pharma R&D teams
- Cell therapy and regenerative medicine service buyers
- Academic core facility and research administration contacts
This event is especially strong for vendors that sell products or services used in:
- Cell culture
- Sample preparation
- Reagents and consumables
- Sequencing and genomics
- Imaging and analysis
- Bioprocessing
- Storage, transport, and cryopreservation
- Scientific software and data management
8️⃣ Client product fit note
I can refine this into a much stronger buyer list once you share the client website. That lets me match the event audience to the client’s actual solution and avoid irrelevant records.
Examples of how the client product changes the target list:
- If the client sells lab instruments or imaging tools, target research directors, core facility managers, and product evaluation teams.
- If the client sells reagents, media, or consumables, target lab managers, procurement contacts, and research group leaders.
- If the client sells cell therapy or bioprocess services, target translational leads, process development heads, and CDMO decision-makers.
- If the client sells clinical research or data services, target physician-scientists, clinical trial teams, and research operations leaders.
- If the client sells software or analytics tools, target bioinformatics leaders, assay developers, and research informatics teams.
9️⃣ Final recommendation
This is a strong event for B2B targeting if your database strategy is focused on scientific and commercial decision-makers rather than general attendees. It is best suited for companies selling products or services into biotechnology, research, clinical development, regenerative medicine, and laboratory operations.
Best buyer segments to collect:
- Principal investigators and research leaders
- Lab directors and core facility managers
- Biotech and pharma R&D teams
- Translational medicine and cell therapy leaders
- Scientific marketing and business development contacts
- Academic and hospital research administrators
- Exhibitors, sponsors, and partner companies
Quality rating for attendee-list / buyer-list sales: 9/10
The audience is highly specialized, international, and commercially valuable. The key to success is segmentation: focus on scientific buyers, lab influencers, translational decision-makers, and industry partners. Once you share the client website, I can build a much sharper target company list with the most relevant titles and industries for this specific event.
Data sheet
| Event Name | ISSCR 2026 Annual Meeting |
| Event Date | 2026-07-08 to 2026-07-11 |
| Event Status | Upcoming |
| Venue | Montreal, Quebec, Canada (specific venue not publicly confirmed in the reviewed official materials) |
| City | Montreal |
| State / Region | Quebec |
| Country | Canada |
| Organizer | International Society for Stem Cell Research (ISSCR) |
| Official Event Website | ISSCR annual meeting official event page on isscr.org |
| Event Type | Scientific conference, research meeting, industry collaboration summit, translational life sciences event |
| Primary Category | Science & Research |
| Secondary Applicable Categories | Medical & Pharma; Biotechnology; Education & Training; IT & Technology |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Medium. Official event pages confirm the meeting and its dates, but a public current-year attendance figure was not identified in the reviewed sources. |
| Main Purpose of Event | To convene stem cell and regenerative medicine researchers, translational scientists, clinicians, biotech and pharma stakeholders, and technology providers for scientific exchange, collaboration, and commercialization discussion. |
The ISSCR Annual Meeting is the flagship global event for the stem cell research community. It brings together academic investigators, translational researchers, clinicians, biotech and pharmaceutical teams, and technology suppliers focused on stem cell biology, regenerative medicine, and adjacent life-science innovation.
From a B2B perspective, the meeting is highly relevant for supplier discovery, research collaboration, lab technology evaluation, scientific services procurement, clinical development networking, and partnership development. It is especially valuable for organizations selling into life sciences, cell and gene therapy, laboratory workflows, imaging, analytics, reagents, software, cold chain, and research infrastructure.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Principal investigators / lab heads | Universities, research institutes, hospitals | Scientific decision-maker; specifies methods and tools | High-value target for reagents, instruments, software, and services |
| Research directors / center directors | Academic medical centers, institutes, biotech R&D | Budget oversight, platform selection, partnership approval | Relevant for strategic lab, translational, and data solutions |
| Translational science leaders | Hospitals, biotech, pharma, CROs | Influence clinical development, assay platforms, and workflow design | Important for clinical research, sample handling, and analytics vendors |
| Core facility managers | Genomics, imaging, flow cytometry, cell culture cores | Operational buyer; evaluates equipment and consumables | Strong fit for lab automation, service contracts, and consumables |
| Procurement / sourcing teams | Universities, hospitals, biotech companies | Vendor onboarding, contract negotiation, price comparison | High relevance for repeatable spend categories and enterprise services |
| Biotech R&D leaders | Cell therapy, gene editing, regenerative medicine firms | Selects vendors, platforms, collaborators, and service providers | Strong fit for tools, software, contract research, and manufacturing partners |
| Clinical research operations | Hospitals, CROs, academic health systems | Trial execution, logistics, protocol support | Relevant for data management, sample logistics, and compliance solutions |
| Pharma innovation / external innovation teams | Large pharmaceutical companies | Partnership scouting, licensing, sponsored research | Important for collaboration, licensing, and platform evaluation |
| Investors / venture teams | Life-science VC, corporate venture, family offices | Capital allocation, diligence, strategic network building | Useful for startup ecosystem targeting and partnership introductions |
| Association leaders / policy stakeholders | Scientific societies, standards groups, advocacy organizations | Influence convening, policy, and standards | Relevant for sponsorship, education, publication, and partnership outreach |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Montreal | Local universities, hospitals, biotech firms, and research institutes | Medium | Strong local academic and life-science ecosystem supports attendance |
| Host region: Quebec | Province-wide research hospitals, universities, biotech, and government science stakeholders | Medium | Likely draw from Montreal, Quebec City, and surrounding life-science corridors |
| Nearby business hubs | Toronto, Boston, New York, Ottawa, Waterloo, Rochester | High | Accessible North American biotech and academic corridor |
| National reach: Canada | National research networks, hospitals, government agencies, investors | High | Canadian life sciences and health research communities are strongly relevant |
| International reach | United States, Europe, Asia-Pacific, Middle East, Latin America | Very High | ISSCR is a globally recognized scientific meeting with cross-border attendance potential |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The ISSCR community is international by nature, with academic, clinical, and commercial participation across multiple countries and regions. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| International Society for Stem Cell Research | Scientific society / organizer | Organizer and audience hub for the event ecosystem | isscr.org | Executive Director, Conference Director, Program Manager | Confirmed Current-Year Participant |
| McGill University | University / research institution | Major Montreal research buyer and attendee source | mcgill.ca | Principal Investigator, Research Director, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Université de Montréal | University / research institution | Regional research leader with stem cell and biomedical activity | umontreal.ca | Lab Director, Core Facility Manager, Research Administrator | Strong Market Fit, Attendance Not Confirmed |
| CHU Sainte-Justine Research Center | Hospital / research center | Clinical and translational research buyer with pediatric and biomedical focus | chu-sainte-justine.org | Clinical Research Director, Lab Manager, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Mila - Quebec AI Institute | Research institute / AI organization | Relevant where AI, data, imaging, and computational biology intersect with stem cell research | mila.quebec | Research Scientist, Partnerships Lead, AI Program Director | Strong Market Fit, Attendance Not Confirmed |
| StemCell Technologies | Life science supplier | Key product and solution provider to stem cell researchers; strong ecosystem relevance | stemcell.com | Product Manager, Scientific Affairs, Sales Director | Strong Market Fit, Attendance Not Confirmed |
| Takeda | Pharmaceutical company | External innovation, cell therapy, and R&D partnership interest | takeda.com | Head of External Innovation, R&D Director, Alliance Manager | Strong Market Fit, Attendance Not Confirmed |
| Bristol Myers Squibb | Pharmaceutical company | Large pharma with interest in cell therapy, translational science, and clinical programs | bms.com | Director of Translational Medicine, Business Development, Procurement | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharmaceutical company | Relevant for advanced therapy, research platforms, and scientific partnerships | novartis.com | Scientific Director, External Innovation Lead, Category Manager | Strong Market Fit, Attendance Not Confirmed |
| Thermo Fisher Scientific | Life science supplier | Major supplier to research labs, imaging, consumables, and workflow buyers | thermofisher.com | Product Marketing Manager, Regional Sales Director, Scientific Application Specialist | Strong Market Fit, Attendance Not Confirmed |
| Illumina | Life science / genomics company | Genomics platform relevant to stem cell characterization and translational workflows | illumina.com | Field Application Scientist, Account Director, Segment Manager | Strong Market Fit, Attendance Not Confirmed |
| Sartorius | Life science supplier | Bioprocessing, cell culture, and lab workflow relevance | sartorius.com | Business Development Manager, Product Manager, Technical Sales Manager | Strong Market Fit, Attendance Not Confirmed |
| Danaher | Life science and diagnostics holding company | Portfolio companies serve research, imaging, and diagnostic buyers | danaher.com | Commercial Leader, Strategy Manager, Product Director | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Principal Investigator / Lab Director | Research | Senior / Executive | Controls scientific direction, budget, and platform selection. |
| 2 | Director of Research / Research Operations | Research Operations | Director / VP | Influences purchasing, workflows, and collaboration strategy. |
| 3 | Clinical Research Director / Translational Medicine Lead | Clinical Research | Director / VP | Evaluates vendors and services tied to patient-facing and translational programs. |
| 4 | Procurement Manager / Strategic Sourcing Manager | Procurement | Manager / Director | Approves suppliers, negotiates contracts, and manages spend. |
| 5 | Core Facility Manager | Scientific Core Facilities | Manager / Senior Manager | Uses and recommends instruments, software, and consumables. |
| 6 | Head of External Innovation / Business Development Director | Business Development | Director / VP | Sources partnerships, licensing, and strategic technology relationships. |
| 7 | Laboratory Manager / Facilities Director | Lab Operations / Facilities | Manager / Director | Oversees equipment, infrastructure, compliance, and support services. |
| 8 | Product Manager / Scientific Affairs Manager | Product / Scientific Affairs | Manager / Director | Represents vendors and helps align solutions to market needs. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Biotechnology | Core industry for stem cell and regenerative medicine stakeholders | R&D, platform, and partnership targeting |
| 2 | Pharmaceuticals | Drug development and translational therapy interest | External innovation, clinical development, procurement |
| 3 | Research | Academic and institute-based scientific users | Principal investigators, research directors, core facilities |
| 4 | Hospital & Health Care | Clinical and translational research settings | Clinical research, diagnostics, workflow, services |
| 5 | Medical Devices | Relevant for instruments, imaging, and lab technologies | Equipment and workflow vendors |
| 6 | Information Technology & Services | Data, software, and computational biology use cases | LIMS, analytics, AI, data platforms |
| 7 | Hospitality | Useful for venue, events, and delegate services procurement | Event sponsors, conference services, travel procurement |
| 8 | Logistics & Supply Chain | Sample handling, cold chain, and shipping relevance | Specimen logistics, storage, and transport solutions |
| 9 | Medical Practice | Clinical leaders participating in translational medicine | Clinical research, therapy enablement, diagnostics |
| 10 | Higher Education | Universities are a major attendee and buyer base | Lab procurement, sponsorship, academic partnerships |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Official event pages reviewed; no public attendance total identified | Use as a high-value niche scientific event, but do not quote a fixed figure without organizer confirmation. |
| Exhibitor count | Not publicly confirmed | Confirmed unavailable | No verified current-year exhibitor total identified in reviewed sources | Potential exhibitor/sponsor interest is expected, but counts should not be assumed. |
| Buyer count | Not publicly confirmed | Confirmed unavailable | Scientific meetings usually do not publish buyer counts | Likely concentrated in research, clinical, and commercial decision-makers. |
| Speaker count | Not publicly confirmed | Confirmed unavailable | Agenda/speaker data not fully verified in the reviewed materials | Speaker mix is typically strong for scientific authority and lead quality. |
| Historical attendance | Prior-year official participation evidence only | Historical / prior-year evidence | Past ISSCR meeting materials and annual-meeting pages | Useful for trend analysis, but not a current-year attendance claim. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Stem cell biology | Validated research tools and protocols | Scientific presentations and lab conversations | Reagents, cell culture systems, assays |
| Regenerative medicine | Translational partners and clinical-grade workflows | Business development and collaboration meetings | Clinical research services, GMP support, analytics |
| Cell therapy | Process development, scale-up, and manufacturing support | Meetings with manufacturing and translational leaders | Bioprocess tools, QA/QC, cold chain logistics |
| Imaging and analytics | High-content analysis and data interpretation | Product demos and workflow optimization discussions | Microscopy, AI analytics, image management software |
| Computational biology / AI | Data integration and predictive modeling | Target research computing and software buyers | Bioinformatics tools, cloud platforms, AI services |
| Clinical translation | Protocol support, compliance, and patient-focused workflows | Engage clinical and hospital stakeholders | CRO services, regulatory support, sample logistics |
| Research procurement | Approved suppliers and contracted pricing | Procurement and sourcing outreach | Catalog sales, contract supply, enterprise procurement |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The audience includes research, clinical, and commercial buyers with active scientific spend. |
| Decision-maker availability | High | Many attendees are senior scientific leaders, lab heads, directors, and partnership executives. |
| Data collection potential | Medium | Strong if exhibitor, speaker, or sponsor lists are published; weaker if attendee list is gated. |
| Apollo targeting potential | Very High | Clear industry, title, and department filters exist for life sciences, biotech, pharma, research, and procurement. |
| Geographic targeting potential | High | Strong Montreal/Quebec/Canada and North American targeting options. |
| Best outreach approach | High-value scientific account-based outreach | Use role-specific messaging tied to research outcomes, workflow improvements, and collaboration opportunities. |
| Overall lead quality | Very High | Strong event for lead generation in life sciences, research tools, clinical translation, and partnership selling. |
| Best use case | Buyer profiling, list building, and conference prospecting | Highly suitable for attendee-list sales, exhibitor targeting, sponsor outreach, and account-based marketing. |
| Limitations / risks | Moderate | Current-year attendee list not publicly verified; avoid claiming confirmed attendance without organizer evidence. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Biotechnology; Pharmaceuticals; Research; Hospital & Health Care; Medical Devices; Information Technology & Services; Higher Education; Government Administration; Life science supplier categories where applicable | Capture scientific buyers, clinical buyers, and commercial partners |
| Departments | Research, Procurement, Operations, Product, Business Development, Clinical, Scientific Affairs, Innovation | Match decision-making functions involved in vendor selection |
| Seniority | Manager, Director, VP, CXO, Partner, Head, Lead | Prioritize budget holders and scientific influencers |
| Job titles | Principal Investigator, Lab Director, Research Director, Director of Translational Medicine, Procurement Manager, Strategic Sourcing Manager, Core Facility Manager, Business Development Director, Head of External Innovation, Product Manager | Direct title-based account targeting |
| Geography | Canada; Quebec; Montreal; United States; Northeast U.S.; Europe; UK; Germany; Japan; South Korea; Singapore | Focus on host-region plus major global life-science hubs |
| Employee size | 11-50; 51-200; 201-500; 501-1000; 1001-5000; 5000+ | Covers startups, research institutes, hospitals, and large pharma |
| Keywords | stem cell, regenerative medicine, cell therapy, translational, tissue engineering, GMP, biobank, cell culture, flow cytometry, imaging, organoid, CRISPR, bioinformatics | Refine for relevant scientific and commercial intent |
| Company type | Public company, private company, university, hospital, research institute, government, nonprofit | Capture both commercial and institutional buyers |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| ISSCR official website | Official organizer website | Organizer identity, annual meeting existence, institutional context | High |
| ISSCR Annual Meeting page | Official event page | Event branding, meeting format, and current annual-meeting reference | High |
| ISSCR meetings overview | Official event listing | Confirms recurring meeting structure and event family positioning | High |
| ISSCR newsroom / announcements | Official press and news source | Event-related updates, program announcements, and historical references | High |
| ISSCR membership / community pages | Official association information | Community composition and attendee-type inference | Medium |
| Venue verification placeholder | Venue research note | No venue-specific confirmation was established in the reviewed sources; venue remains unconfirmed from public materials reviewed | Low |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to ISSCR 2026 Annual Meeting — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.